This statistic depicts the pharmaceutical company ranking based on public policy and market influence in developing countries in 2018 , according to the Access to Medicine Index . In that year , the company with the highest score in public policy and market influence in these countries was GlaxoSmithKline , scoring 4.01 points . The Access to Medicine Index is an independent initiative that ranks the world 's 20 largest companies according to their efforts to make their products more available , affordable and accessible in developing countries , highlighting policy and practice that either facilitate or hinder access to medicine .
